{"id":"W2031806630","doi":"10.1007/s00213-009-1506-7","title":"The future of endocannabinoid-oriented clinical research after CB1 antagonists","year":2009,"lang":"en","type":"article","venue":"Psychopharmacology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre for Addiction and Mental Health; University of Toronto","funders":"National Institutes of Health; Pfizer","keywords":"Rimonabant; Endocannabinoid system; Cannabinoid receptor; Medicine; Addiction; Cannabis; Clinical trial; Drug class; Anxiety; Psychiatry; Drug; Psychology; Pharmacology; Internal medicine; Antagonist","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009323181,0.0008851633,0.002498865,0.001391967,0.001339732,0.004005854,0.001784172,0.004733151,0.00992467],"category_scores_gemma":[0.005591009,0.0003080572,0.0009298571,0.001331527,0.003871146,0.006641472,0.001327452,0.004071549,0.001998461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002580815,"about_ca_system_score_gemma":0.006924275,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00176519,"about_ca_topic_score_gemma":0.00400747,"domain_scores_codex":[0.9983014,0.0008217203,0.0001577495,0.0002001907,0.0002361851,0.0002826817],"domain_scores_gemma":[0.9935875,0.003955672,0.0004044979,0.0003145699,0.001131479,0.000606232],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.008943159,0.002251565,0.002124987,0.004573544,0.0001666034,0.0009706156,0.000516687,0.000508749,0.01528602,0.05520973,0.02790399,0.8815444],"study_design_scores_gemma":[0.003644078,0.01383861,0.01086841,0.009450967,0.0007535339,0.00360719,0.002369689,0.002143468,0.008483443,0.1653221,0.7791895,0.0003289623],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.01260757,0.8826626,0.004441543,0.0719882,0.004510485,0.0001539577,0.0001624835,0.0001049028,0.02336836],"genre_scores_gemma":[0.134939,0.7667807,0.01153098,0.05580812,0.0198737,0.0004276,0.0003063368,0.00006222448,0.01027134],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00992467,"threshold_uncertainty_score":0.04930627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03286631220363982,"score_gpt":0.4664869895947069,"score_spread":0.4336206773910671,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}